Gutierrez A C, Vincent R G, Sandberg A A, Takita H, Stanley K
J Thorac Cardiovasc Surg. 1979 Mar;77(3):392-5.
We evaluated sternal bone marrow aspiration as a routine pretreatment procedure in patients with bronchogenic carcinoma. The overall rate of identification of tumor cells by this technique was found to be low. When oat cell bronchogenic carcinoma was considered as a separate entity, the positive rate was higher. However, in no instance did the bone marrow aspiration result in a change in clinical staging.
我们评估了胸骨骨髓穿刺术作为支气管源性癌患者的常规预处理程序。通过该技术识别肿瘤细胞的总体比率较低。当将燕麦细胞支气管源性癌视为一个单独的实体时，阳性率较高。然而，骨髓穿刺术在任何情况下都未导致临床分期的改变。
